Keratin 1 (K1) is a novel receptor, present on the surface of cancer cells (breast and neuroblastoma) [23,24,25] and cells that have undergone oxidative stress [26], that is being used for targeted drug delivery. This evidence concerns the gene KRT1 and cancer.